01 20Boehringer lngelheim Animal Health Canada Inc.
02 10Elanco, Division Eli Lilly Canada Inc.
03 4Gowling WLG (Canada) LLP
04 5Gowling WLG LLP
01 52379329
02 52460692
03 42531150
04 52632694
05 52684632
06 52747354
07 52863498
08 52966703
01 20AFOXOLANER | MILBEMYCIN OXIME
02 5LOTILANER | MILBEMYCIN OXIME
03 4MILBEMYCIN OXIME | PRAZIQUANTEL
04 10Spinosad | Milbemycin Oxime
01 10Chewable Tablet
02 29TABLET (CHEWABLE)
01 52020-08-02
02 52021-09-17
03 42024-07-29
04 52026-12-28
05 52028-06-20
06 52029-12-17
07 102033-01-31
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Brand Name : TRIFEXIS
Patent Number : 2460692
Filing Date : 2001-09-17
Strength per Unit : 140 mg / 2.3 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Brand Name : TRIFEXIS
Patent Number : 2460692
Filing Date : 2001-09-17
Strength per Unit : 270 mg / 4.5 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Brand Name : TRIFEXIS
Patent Number : 2460692
Filing Date : 2001-09-17
Strength per Unit : 560 mg / 9.3 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Brand Name : TRIFEXIS
Patent Number : 2379329
Filing Date : 2000-08-02
Strength per Unit : 140 mg / 2.3 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Brand Name : TRIFEXIS
Patent Number : 2379329
Filing Date : 2000-08-02
Strength per Unit : 270 mg / 4.5 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Brand Name : TRIFEXIS
Patent Number : 2379329
Filing Date : 2000-08-02
Strength per Unit : 560 mg / 9.3 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Brand Name : TRIFEXIS
Patent Number : 2460692
Filing Date : 2001-09-17
Strength per Unit : 810 mg / 13.52 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Brand Name : TRIFEXIS
Patent Number : 2379329
Filing Date : 2000-08-02
Strength per Unit : 810 mg / 13.52 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Brand Name : TRIFEXIS
Patent Number : 2460692
Filing Date : 2001-09-17
Strength per Unit : 1620 mg / 27.04 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2021-09-17
Date Granted : 2012-12-18
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
Brand Name : TRIFEXIS
Patent Number : 2379329
Filing Date : 2000-08-02
Strength per Unit : 1620 mg / 27.04 mg
Dosage Form : Chewable Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-08-02
Date Granted : 2009-10-20
